A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

Clinical trial NCT06856200 · RECRUITING

Trial details

NCT number: NCT06856200
Sponsor: Fudan University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced HR - Positive, HER2 - Negative Breast Cancer Resistant to (Neo)Adjuvant Endocrine Therapy

Start date: 2025-02-28
Primary completion: 2025-10-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.